Thomson Reuters Bayer’s shares dropped 12% after a jury found a customer developed cancer from using its Roundup weed-killer. The finding comes after another jury found Bayer’s Monsanto unit failed to warn customers of the potential cancer risks of its weed-killers. Shares in Bayer plunged 12% in morning trading after a San Francisco jury found […]